Myriad Genetics Inc (MYGN)

R&D to Revenue

13.11%

Quarterly · Period ending:

MYGN logo

MYGN R&D to Revenue

Latest reported13.11%
MYGN Quarterly R&D/Revenue (0.00% → 13.11%)
High-resolution chart · PNG

MYGN r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
66.974%
72.8644%
78.2257%
81.2514%
84.8939%
85.7746%
74.6988%
84.058%
85.5072%
86.3764%
100%
103.5714%
96.9231%
96.4912%
98.0392%
105.0847%
69.3333%
155.5556%
178.5714%
186.3636%
210%
194.7368%
164.7059%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.